Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| DNTH | NASDAQ | Dianthus Therapeutics, Inc. | $104.98 | -0.70% | 828K | $4.34B |
| WAY | NASDAQ | Waystar Holding Corp. | $22.51 | +4.31% | 2.2M | $4.32B |
| LIVN | NASDAQ | LivaNova PLC | $78.19 | -0.53% | 412K | $4.3B |
| ACAD | NASDAQ | ACADIA Pharmaceuticals Inc. | $25.43 | +1.36% | 1M | $4.25B |
| LFST | NASDAQ | LifeStance Health Group, Inc. | $11.58 | +2.57% | 1.8M | $4.23B |
| LEGN | NASDAQ | Legend Biotech Corporation | $22.22 | -5.57% | 1.7M | $4.11B |
| DYN | NASDAQ | Dyne Therapeutics, Inc. | $24.44 | +2.30% | 5.1M | $4.04B |
| VKTX | NASDAQ | Viking Therapeutics, Inc. | $34.79 | -1.70% | 1.8M | $4.04B |
| CELC | NASDAQ | Celcuity Inc. | $82.62 | -6.47% | 1.3M | $4.03B |
| ALHC | NASDAQ | Alignment Healthcare, Inc. | $20.77 | -3.40% | 2.9M | $4.02B |
| ICUI | NASDAQ | ICU Medical, Inc. | $157.44 | +2.59% | 259K | $3.93B |
| CPRX | NASDAQ | Catalyst Pharmaceuticals, Inc. | $31.49 | 0.00% | 0 | $3.85B |
| ELVN | NASDAQ | Enliven Therapeutics, Inc. | $52.95 | +0.27% | 369K | $3.78B |
| DNLI | NASDAQ | Denali Therapeutics Inc. | $23.11 | -1.32% | 1.2M | $3.67B |
| IRTC | NASDAQ | iRhythm Technologies, Inc. | $109.20 | +1.42% | 318K | $3.59B |
| NAMSW | NASDAQ | NewAmsterdam Pharma Company N.V. | $19.00 | -7.59% | 0 | $3.56B |
| ADPT | NASDAQ | Adaptive Biotechnologies Corporation | $22.27 | -0.18% | 2.8M | $3.56B |
| NAMS | NASDAQ | NewAmsterdam Pharma Company N.V. | $30.55 | -3.63% | 1.1M | $3.47B |
| TLX | NASDAQ | Telix Pharmaceuticals Limited | $10.51 | +1.84% | 83K | $3.46B |
| ALMS | NASDAQ | Alumis Inc. | $28.00 | -1.06% | 1.2M | $3.46B |
| ORKA | NASDAQ | Oruka Therapeutics, Inc. | $92.53 | -1.90% | 579K | $3.45B |
| ARQT | NASDAQ | Arcutis Biotherapeutics, Inc. | $27.35 | +0.07% | 819K | $3.42B |
| OPCH | NASDAQ | Option Care Health, Inc. | $21.27 | -1.87% | 1.6M | $3.4B |
| IDYA | NASDAQ | IDEAYA Biosciences, Inc. | $35.00 | -2.75% | 902K | $3.37B |
| TNGX | NASDAQ | Tango Therapeutics, Inc. | $26.63 | -2.99% | 2.5M | $3.31B |
| RLAY | NASDAQ | Relay Therapeutics, Inc. | $19.27 | -0.16% | 2M | $3.23B |
| PRVA | NASDAQ | Privia Health Group, Inc. | $25.37 | -3.57% | 910K | $3.21B |
| VCRE | NASDAQ | Vicore Pharma Holding AB | $11.39 | -1.98% | 2K | $3.2B |
| ACHC | NASDAQ | Acadia Healthcare Company, Inc. | $34.51 | +1.47% | 2.3M | $3.17B |
| MBX | NASDAQ | MBX Biosciences, Inc. Common Stock | $62.00 | -2.47% | 501K | $2.95B |
| GRAL | NASDAQ | GRAIL Inc. | $67.84 | -3.58% | 350K | $2.91B |
| IRON | NASDAQ | Disc Medicine, Inc. | $74.12 | -2.29% | 403K | $2.83B |
| RGC | NASDAQ | Regencell Bioscience Holdings Limited | $5.72 | +1.78% | 161K | $2.83B |
| GPCR | NASDAQ | Structure Therapeutics Inc. | $49.12 | -3.31% | 655K | $2.83B |
| ESTA | NASDAQ | Establishment Labs Holdings Inc. | $92.32 | +1.34% | 208K | $2.72B |
| SUPN | NASDAQ | Supernus Pharmaceuticals, Inc. | $46.20 | -2.10% | 522K | $2.68B |
| ATAI | NASDAQ | Atai Beckley Inc. | $7.18 | +0.14% | 7M | $2.66B |
| QURE | NASDAQ | uniQure N.V. | $38.97 | -1.17% | 1.3M | $2.65B |
| RARE | NASDAQ | Ultragenyx Pharmaceutical Inc. | $26.90 | -0.44% | 1.5M | $2.65B |
| KOD | NASDAQ | Kodiak Sciences Inc. | $41.41 | +0.95% | 513K | $2.59B |
| XRAY | NASDAQ | DENTSPLY SIRONA Inc. | $12.72 | -4.14% | 4M | $2.59B |
| BEAM | NASDAQ | Beam Therapeutics Inc. | $26.64 | -2.38% | 1.8M | $2.58B |
| VERA | NASDAQ | Vera Therapeutics, Inc. | $36.06 | -3.00% | 786K | $2.54B |
| TARS | NASDAQ | Tarsus Pharmaceuticals, Inc. | $57.58 | +0.56% | 446K | $2.52B |
| TMDX | NASDAQ | TransMedics Group, Inc. | $72.26 | +1.59% | 1.1M | $2.5B |
| TRVI | NASDAQ | Trevi Therapeutics, Inc. | $17.54 | +2.07% | 1.7M | $2.49B |
| PGNY | NASDAQ | Progyny, Inc. | $31.19 | +1.60% | 645K | $2.44B |
| NRIX | NASDAQ | Nurix Therapeutics, Inc. | $23.38 | -1.52% | 833K | $2.43B |
| PHVS | NASDAQ | Pharvaris N.V. | $34.36 | -0.26% | 256K | $2.39B |
| BCRX | NASDAQ | BioCryst Pharmaceuticals, Inc. | $9.29 | +2.03% | 1.9M | $2.37B |